Monsanto acquires Rosetta Green activity
Monsanto is paying NIS 126 million, a 90% premium, for the activity of the crop bioengineering company.
Monsanto will apparently pay $35 million for Rosetta Green, plus $2 million in milestone payments. Rosetta Green's share price rose 4.1% on Thursday to NIS 6.54, giving a market cap of NIS 66 million. Monsanto is paying a 90% premium on the market cap.
Monsanto is acquiring Rosetta Green's activity, not the company, which will become a cash-rich stock market shell. Monsanto is best known in Israel for its $35 million investment in crop bioengineering company Evogene Ltd. (TASE:EVGN) and signing a cooperation agreement with it, which could potentially be worth hundreds of millions of dollars to Evogene.
Published by Globes [online], Israel business news - www.globes-online.com - on February 3, 2013
© Copyright of Globes Publisher Itonut (1983) Ltd. 2013
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options